Dow Plunges into Correction Territory: Here’s How Bad Friday’s Market Bloodbath Was
U.S. stocks closed sharply lower on Friday as slowing growth in China and worries about a possible rate hike by the Fed took their toll. The Dow Jones Industrial Average finished the day down 531 points for a 3.12 percent loss. The S&P lost 65 points (-3.16 percent) — its worst day since Aug. 8, 2011 — and the Nasdaq lost 171 (-3.52 percent). For the first time since 2011, the Dow is now in a correction, meaning it has lost 10 percent from its peak. The S&P is nearing correction territory, too, having lost 7.5 percent since its May 21 closing high.
Related: The Stock Market's Fed Fever Is Only Going to Get Worse
The selloff was widespread, with 491 of the S&P 500 stocks ending the day in the red and only 11 managing to advance (the S&P 500 actually includes 502 stocks). For the week, 487 of the S&P 500 stocks fell and only 15 gained. In total, the S&P 500 lost a collective $1.14 trillion in market value on the week. Yes, trillion with a "T."
This snapshot from finviz of the performance of stocks in the S&P 500 gives a sense of Friday's carnage (Click it to enlarge):
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
